Cargando…
Development and validation of a nomogram for predicting survival in patients with malignant myofibroblastic tumor
BACKGROUND: Malignant myofibroblastic tumors are a rare group of soft tissue sarcomas, for which a prognosis prediction model is lacking. Based on the Surveillance, Epidemiology, and End Results (SEER) database and cases from Nanjing Drum Tower Hospital, the current study constructed and validated a...
Autores principales: | Wang, Xiaolu, Liu, Baorui, Li, Rutian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166985/ https://www.ncbi.nlm.nih.gov/pubmed/36951597 http://dx.doi.org/10.1002/cam4.5668 |
Ejemplares similares
-
Development and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patients
por: Shao, Yiming, et al.
Publicado: (2023) -
Development and validation of a nomogram for predicting cancer-specific survival in patients with Wilms' tumor
por: Pan, Zhenyu, et al.
Publicado: (2019) -
Develop and validate nomogram to predict cancer-specific survival for patients with testicular yolk sac tumors
por: Li, Maoxian, et al.
Publicado: (2022) -
Development and Validation of a Nomogram for Predicting Overall Survival in Pancreatic NeuroendocrineTumors()()
por: Miao, Dong-liu, et al.
Publicado: (2018) -
Development and validation of a nomogram to predict the overall survival of patients with neuroblastoma
por: Liu, Qinglin, et al.
Publicado: (2020)